An interventional study of Deterra activated charcoal pouch in Pain, Acute, Opioid Misuse and Obstetric Pain, sponsored by Geisinger Clinic. Completed at 1 site in United States. Open to female participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-19.
Sponsored by Geisinger Clinic · Not applicable, Interventional, and Prevention
Background: There is scarce literature investigating how patients dispose of unused opioid supplies after their cesarean postoperative pain has faded. The Office of the Surgeon General has identified research on the prevention of opioid use disorder area as well as research on the management of pain as a "Surgeon General Priority" that needs urgent investigation.
Hypothesis: At least 33% of postpartum women discharged home with an opioid prescription and a drug deactivation pouch will use the pouch to dispose of remaining opioids within 30 days of delivery.
Methods: This is a prospective single arm interventional pilot study.
396 studies on the registry are indexed under Labor Pain; 66 are open to participants now.
This study's enrollment of 37 is below the median of 100 across 326 interventional studies indexed under Labor Pain.
Browse Labor Pain studies →Geisinger Clinic is the lead sponsor of 125 studies on the registry; 21 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 7 (78%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
Documented history, per ERM:
The patients in this arm will receive an activated charcoal pouch (Deterra Medium Pouch, UPC #: 850006727001, Verde Environmental Technologies, Minnetonka, MN) for disposal of their opioids after their cesarean delivery pain has resolved.
Other: Deterra activated charcoal pouch
drug disposal pouch
Actual pouch use
The percentage of women who used the pouch to dispose of opioids in the home 30 days after delivery (%)
Time frame: 30 days
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Geisinger Clinic